
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 08 February 2021
Sec. Pharmacogenetics and Pharmacogenomics
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.646111
This article is part of the Research Topic Coronavirus Disease (COVID-19): Molecular Mechanisms, Translational Approaches and Therapeutics View all 118 articles
This article is a correction to:
COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses
A corrigendum on
COVIEdb: A database for potential immune epitopes of coronaviruses
by Wu, J., Chen, W., Zhou, J., Zhao, W., Chen, S., and Zhou, Z. (2020). Front. Pharmacol. 11:572249. doi: 10.3389/fphar.2020.572249
In the original article, there was an incorrect reference.
A correction has been made to the reference for MixMHC2pred in the Methods section. It was incorrectly written as Chen, B., Khodadoust, M. S., Olsson, N., Wagar, L. E., Fast, E., Liu, C. L., et al. (2019). Predicting HLA class II antigen presentation through integrated deep learning. Nat. Biotechnol. 37, 1332–1343. doi: 10.1038/s41587-019-0280-2. It should be Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., et al. (2019). Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes. Nat. Biotechnol. 37, 1283–1286. doi: 10.1038/s41587-019-0289-6.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: coronavirus, epitopes, Vaccine, database, COVID-19
Citation: Wu J, Chen W, Zhou J, Zhao W, Sun Y, Zhu H, Yao P, Chen S, Jiang J and Zhou Z (2021) Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses. Front. Pharmacol. 11:646111. doi: 10.3389/fphar.2020.646111
Received: 25 December 2020; Accepted: 30 December 2020;
Published: 08 February 2021.
Edited and reviewed by:
Frontiers in Pharmacology Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Wu, Chen, Zhou, Zhao, Sun, Zhu, Yao, Chen, Jiang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jianmin Jiang, am1qaWFuZ0BjZGMuemouY24=; Zhan Zhou, emhhbnpob3VAemp1LmVkdS5jbg==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.